Medical Marijuana, Inc. Records Best Revenue Quarter in Company History

by adminTorusBrand | May 22, 2019 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, Kannaway

Important achievements from across our portfolio of companies helped drive record revenue and continued success in the opening months of 2019. Medical Marijuana, Inc. and our portfolio of companies and investments continued our upward trend in the first fiscal quarter...

AXIM® Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment

by adminTorusBrand | May 20, 2019 | Axim Biotechnologies, Company News

Medical Marijuana, Inc. investment AXIM® Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines. Leading cannabinoid research and new drug development company AXIM® Biotechnologies recently filed...

How Medical Marijuana, Inc. Worked to Advance the Cannabis Industry in the Past Year

by adminTorusBrand | Apr 19, 2019 | Axim Biotechnologies, Company News, Dixie Botanicals, HempMeds, HempMeds Brasil, Kannaway, Real Scientific Hemp Oil

This 4/20, we look at how our family of companies have helped to support the cannabis industry, consumers, and patients around the world. The cannabis industry and cannabis enthusiasts pause this 4/20 to celebrate all things cannabis, including the rapid expansion of...

AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments

by adminTorusBrand | Apr 11, 2019 | Axim Biotechnologies, Company News

Recent agreement with research organization initiates studies on potential cannabinoid treatments for drug-related psychosis and chemotherapy-related nausea in cancer and AIDS patients. Medical Marijuana, Inc. investment AXIM® Biotechnologies has taken an important...

Medical Marijuana, Inc. Family of Companies Surpass Last Year’s Revenue with 5 Months Left in 2018

by adminTorusBrand | Aug 3, 2018 | Axim Biotechnologies, Company News, HempMeds, Kannalife, Kannalife Sciences, Kannaway

Medical Marijuana, Inc. rides momentum from first half of the year to pass last year’s revenue numbers with just five months left in 2018 Medical Marijuana, Inc. started off the year on the right foot in January – hitting record revenue numbers for the month. It is a...

Medical Marijuana, Inc. Major Investment AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules

by adminTorusBrand | Feb 28, 2018 | Axim Biotechnologies, Press Releases

SAN DIEGO, Feb. 28, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its major investment company AXIM® Biotechnologies (OTC:AXIM) (“AXIM”) has successfully executed their...